Your browser doesn't support javascript.
loading
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Crump, Nicholas T; Smith, Alastair L; Godfrey, Laura; Dopico-Fernandez, Ana M; Denny, Nicholas; Harman, Joe R; Hamley, Joseph C; Jackson, Nicole E; Chahrour, Catherine; Riva, Simone; Rice, Siobhan; Kim, Jaehoon; Basrur, Venkatesha; Fermin, Damian; Elenitoba-Johnson, Kojo; Roeder, Robert G; Allis, C David; Roberts, Irene; Roy, Anindita; Geng, Huimin; Davies, James O J; Milne, Thomas A.
Affiliation
  • Crump NT; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK. n.crump@imperial.ac.uk.
  • Smith AL; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, W12 0NN, UK. n.crump@imperial.ac.uk.
  • Godfrey L; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Dopico-Fernandez AM; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Denny N; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Harman JR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Hamley JC; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Jackson NE; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Chahrour C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Riva S; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Rice S; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Kim J; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Basrur V; Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, 34141, South Korea.
  • Fermin D; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Elenitoba-Johnson K; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
  • Roeder RG; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Allis CD; Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, 10065, USA.
  • Roberts I; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, 10065, USA.
  • Roy A; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Geng H; Department of Paediatrics, University of Oxford, Oxford, OX3 9DU, UK.
  • Davies JOJ; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Milne TA; Department of Paediatrics, University of Oxford, Oxford, OX3 9DU, UK.
Nat Commun ; 14(1): 5208, 2023 08 25.
Article in En | MEDLINE | ID: mdl-37626123

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Type: Article Affiliation country: United kingdom